Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 6Neoplasms 3Melanoma 3Colorectal Neoplasms 3Neoplasm Metastasis 2Carcinoma 2Breast Neoplasms 2Thyroid Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms by Site 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liposarcoma 1Glioma 1Gastrointestinal Stromal Tumors 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1Brain Diseases 1Advanced Non-small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 3Carboplatin 3selpercatinib 2Radiotherapy 2Cisplatin 2regorafenib 1pentetreotide 1pembrolizumab 1glutathione pegylated liposomal doxorubicin 1etoposide phosphate 1carboxyamido-triazole 1budigalimab 1binimetinib 1aflibercept 1Trastuzumab 1Temozolomide 1Taxes 1Tamoxifen 1Quality of Life 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1PF-07284890 1Nivolumab 1NEO212 1Molecular Diagnostic Techniques 1Midazolam 1Levofloxacin 1Lapatinib 1Ipilimumab 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Midazolam × Thoracic × Clear all
NCT04543188 2025-10-23

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Pfizer

Phase 1 Terminated
65 enrolled 52 charts
CNSDermatologicThoracic

Brain Diseases, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡